Format

Send to

Choose Destination
See comment in PubMed Commons below
Inflamm Bowel Dis. 2010 Mar;16(3):537-8. doi: 10.1002/ibd.21078.

Veto on vedolizumab (MLN0002) for Crohn's disease.

Author information

1
Department of Medicine, Division of Gastroenterology and Hepatology, Charité Medical Center, Virchow Hospital, Medical School of the Humboldt, University of Berlin, Berlin, Germany.

Comment in

PMID:
19685452
DOI:
10.1002/ibd.21078
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center